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Abstract
Purpose. Post-operative radiotherapy (RT) is routinely applied in the treatment of several human tumours. The aim of
the present study was to investigate the value of post-operative RT in a rat model.
Methods. Experiments were performed using the rhabdomyosarcoma R1H of the WAG/Rij rat. Animals were randomized
to different treatment schedules: surgery, RT or a combination of both. Tumours were excised at different sizes (0.1-4.5 g)
aiming for complete macroscopic resection. RT (60 Gy in 30 daily fractions over 6 weeks) was applied either primarily or to
the former turnout site from the third post-operative day. Turnout growth delay, time to recurrence and local turnout control
were used as endpoints.
Results. Pre-operative tumour size determined the time and rate of recurrence. The larger the turnout, the shorter the
time to relapse and the higher the recurrence rate. The 50% local control rate (LCRs0) for surgery was found in tumours
with a mass of 0.8 g. For post-operative RT a LCRs0 was achieved for tumours with a mass of 1.1 g. For larger turnouts
> 1.1 g), however, the rate and time course of relapse were similar for both the group receiving RT alone and the group
receiving post-operative RT.
Discussion. In this model the turnout mass at excision governs the prognosis. Relatively small R1H turnouts may recur
despite complete macroscopical resection. With regard to the LCR, the outcome for larger tumours is improved with
post-operative RT (60 Gy/6 weeks) than compared with surgery alone. The factor is 1.3. Within a certain range of tumour
sizes, combined treatment (surgery + RT) can improve the outcome considerably.
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Introduction
Radical surgical intervention for tumour excision is
limited in many cases due to the need to maintain
the function of the normal organs concerned. How-
ever, one drawback of sparing normal tissue is the
enhanced risk of tumour recurrence. Radiotherapy
(RT) is a very important additional treatment
modality and is a generally accepted approach in
curative tumour therapy. When applied post-opera-
tively, RT aims to sterilize tumour cells that might
possibly, if not definitely, have remained in situ at
the time of surgical intervention. Of all the cancer
patients who undergo surgery, 30-40% are irradi-
ated post-operatively. A number of questions linked
with post-operative RT have yet to be answered,
such as at which stage and in which situation will
patients profit most.
It appears obvious that the recurrence rate
increases with increasing tumour size. In spite of
this the actual tumour stage is a poor prognostic
parameter. Moderate treatment radicalism in so-
called ’low risk’ patients can theoretically invert the
risk situation. While aiming for small improvements
in higher stage tumours, many therapists consider
results in early cancers to be sufficient, despite the
fact that they can still be improved. For stage I and
II gynaecological cancers, it has been shown that
treatment results can be improved by post-operative
RT.3’4 The same is true for head and neck tumours.
Accordingly, even small breast cancers require 50-
60 Gy in breast-conserving treatment due to their
multi-focal nature. 6’7 For sarcomas, it has been
demonstrated that the metastatic rate increases con-
8 siderably after local recurrences.
Baker et al.
9 have performed a study on different
experimental tumours. They showed that tumours
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tend to grow better in a post-operative situation--
this was attributed to the expression of specific
growth factors in the operation wound. Thus, theo-
retically, cells remaining post-operatively represent
the risk of a local recurrence, and may further
accelerate the course of the disease unless a valid
adjuvant treatment such as RT is applied. In
addition, it has been shown for breast cancers
1 and
sarcomas
11 that local recurrences can have a nega-
tive impact on the survival rate. Thus, local control
represents a function of prognosis.
12
The rhabdomyosarcoma RIH of the rat has been
found to be suitable for experimenthl studies of
post-operative RT. 13 The present animal study
addressed the question of the role of tumour volume
at surgery, the recurrence rate as a function of
tumour mass at excision and the value of post-
operative adjuvant RT.
Materials and methods
Experiments were performed using the rhab-
domyosarcoma R1H of the WAG/Rij rat .(with no
signs of specific immunogenicity).
14 Tumour pieces
of about 1 mm
3 in size (approx. 106 cells) were
transplanted to the right flank of the animals
under general anaesthesia. Two to three weeks
after implantation the tumours reached treatment
size. 13
A total of 131 animals were randomized to differ-
ent treatment schedules consisting of RT (control;
n- 8), surgery (n- 102) or a combination of both
(n- 21). One animal was lost due to intercurrent
disease. Control animals were primarily irradiated
when their tumours reached the median size of
0.73 cm
3 (range 0.6-1.3 cm). Tumours were
excised at different sizes (range 0.1-4.5 g). The
extent of excision was limited to the intact pseudo-
capsule aiming for complete macroscopic resec-
tion.1 None of the animals showed signs of residual
tumour masses post-operatively. Local metastatic
spread to lymph nodes was not seen.
Tumours and former tumour sites were irradiated
locally using 200 kVp X-rays under ambient condi-
tions. 15 RT consisted of five fractions of 2 Gy/week
over a period of 6 weeks. Thus, total doses of 60 Gy
were applied. In the adjuvant situation, RT was
performed from the third post-operative day.
Following treatment, animals were observed three
times a week. Size-dependent recurrence rates, as
well as specific patterns of treatment response, were
subject to further evaluation. Delay in tumour
growth was defined as the time to regrow to the start
volume V0. To evaluate the mass-dependent recur-
rence rates, the range of tumour masses was divided
into 10 equal intervals on a logarithmic scale (Fig.
1). The actual recurrence rates were then calculated
for each intercept and approximated using the maxi-
mum likelihood method and assuming Poisson
100
75
o 50
o 2
10
17 o
6 1
14 /o
23/
L  Oo/
II
O.5 3 5
/
0.1 0[3
Tumour mass at excision (g)
Fig. 1. Tumour recurrence rate of the rhabdomyosarcoma
R1H in the ratfollowing surgery as a function of tumour mass
at excision. The graph also includes animals that received RT,
as accumulatedradiation dose early in the course oftreatmentwas
unable to prevent temporary recurrence (cf. Fig. 3).
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Fig. 2. There is a correlation between the latency period
following surgery and the tumour mass. Latency decreases with
increasing tumour mass (p < O. 001).
statistics. The non-parametric Spearman’s rank cor-
relation coefficient was used to test for a possible
correlation between latency time and tumour mass
(Fig. 2). Animals that were free of tumour 140 days
after the start of treatment were defined to be
cured.
The experiments were performed according to the
regulations of the veterinarian inspection.
Results
Surgical curability of the rhabdomyosarcoma R1H
of the rat is strongly linked to the tumour mass at
excision. After surgery alone, tumours show a 50%
local control rate (LCRs0) at a median mass ofTable 1. Tumour mass as afunction ofrecurrence (R) or cure
(C) in tumours receiving 60 Gypost-operatively, also taking into
account the clinical observation of temporary recurrences
Tumour mass at Temporary
excision (g) recurrence Final outcome
0.65 Yes C
0.7 C
0.7 C
0.7 Yes C
0.7 Yes C
0.8 C
0.8 Yes C
0.8 C
0.9 C
0.9 Yes C
0.9 Yes C
1.0 C
1.1 C
1.1 Yes R
1.5 Yes R
1.5 Yes R
2.5 Yes R
2.5 Yes R
3.0 Yes R
3.8 Yes R
There is a significant distinction (Z2-test: p<0:0001)
between the mass oftumours that are finally cured (cf. Fig.
3: O) and those that recur (cf. Fig 3: O). Without RT,
temporary recurrences would definitely lead to immediate
recurrences. This can be avoided (< 1.1 g) or postponed
(> 1.1 g) by applying 60 Gy post-operatively.
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recur (Fig. 1). The graph in Fig. 1 also includes
those animals which received post-operative RT
(Table 1), as temporary tumours occurred in 13
animals early during RT. Temporary recurrences
are defined as tumour recurrences which can be
detected shortly after the surgery, and then vanish
due to post-operative RT using 60 Gy. In larger
tumours (> 1.1 g; n-8) a short period of local
control was achieved following 60 Gy, after which
turnouts recurred. In contrast, smaller turnouts
< 1.1 g; n- 12) were sterilized at the end ofRT in
spite of temporary recurrences. All recurrences were
located within 1.0 cm of the former core of the
primary. In most cases the pattern of regrowth was
multi-focal. Figure 2 shows that the time to recur-
rence ranged from 3 to 42 days and decreased with
increasing tumour mass (p < 0.001).
In Figure 3, median growth curves are presented
for the different treatment groups. Tumours receiv-
ing 60 Gy irradiation achieved a growth delay of 100
days. Turnouts recurred even during post-operative
irradiation; however, turnouts smaller than 1.1 g
could be cured by post-operative RT. Tumours
1.1 g or more vanished beyond the limits of detect-
ability at the end of RT. The median length of this
interval of ’complete response’ was 3 weeks. For
recurring larger tumours (> 1.1 g) that were irrad-
iated post-operatively, the time to regrowth was
similar to that for turnouts that were irradiated only
(Fig. 3).
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Fig. 3. The relative tumour volume of rhabdomyosarcoma
R1H in rats irradiated with 30fractions of2 Gy within 6 weeks
is shown as afunction oftime after start oftreatment (X ). The
figure shows the growth curves ofthe individual tumours with the
median response: [, untreated control turnouts (historical data,
redrawn in partsfrom Carl13); V, RT alone (n 8); O, local
tumour excision (> 1.1 g) andpost-operative RT using 60 Gy
(n 12); local turnour excision (> 1. I g) andpost-operative
nT using 60 6y (n 8).
0.8 g (range 0.7-1.0 g). Below 0.4 g, few recurrences
were seen within 140 days of the surgery, but
tumours larger than 3.0 g were almost certain to
Discussion
The present study shows that there is a sigmoid
relation between tumour mass at resection and
recurrence rate for the experimental rhabdomyosar-
coma R1H of the rat (Fig. 1). A preformed tumour
bed and the activation of growth factors in the
operation wound may have an important impact on
the patterns of regrowth, which is faster than after
tumour transplantation. The growth kinetics appear
to be dependent of the tumour mass at excision
(Fig. 2).
Both the present study and former data showed a
growth delay of 100 days without any local controls
following RT alone using 60 Gy. This was indepen-
dent of the initial tumour size (Fig. 3).
14 Surgery
alone achieved a local control rate of only 50% in
tumours with a maximal size of 0.8 g. This figure
can be as high as 1.1 g when applying 60 Gy
post-operatively. Compared to the results for
surgery alone, combined treatment significantly
(p< 0.0001) pushed up the limits of curability by a
factor of 1.3. Large tumours (> 1.1 g range 1.1-
3.8 g) recur despite applying 60 Gy after complete
macroscopic excision. The latter show a growth
delay that is not different from tumours (0.6-
1.3 cm3) that have received RT alone (60 Gy). A
radiation-induced tumour bed effect can only be
seen in the group treated with RT alone. Growth146 U.M. Carl et al.
delay not only reflects the effect of irradiation on the
tumour cells but also on the stroma, which shows a
typical influence on the regrowth pattern following
irradiation16 (cf. Fig. 3).
R1H tumours grow in a pseudo-capsule. Macro-
scopically, multi-focality is rarely seen in tumours of
the size range investigated. Despite complete
macrosopical excision the recurrence rate was
dependent on the tumour mass. Due to the localiza-
tion of the recurrences, it does not appear likely
that turnout cells are spread in surgery. More-
over, turnout cells outside the pseudo-capsule
can cause recurrences in the surgical approach
described. Accordingly, tumour cells may be able to
cross the capsule and subsequently invade the near
vicinity.
17
The results suggest that, for the R1H tumour
system, the extent of remaining turnout formation is
a considerable factor in recurrence. Tumour ceils
migrate eccentrically from the core of a tumour.
During the time the primary tumour has to grow,
remote cells begin new clones with growth character-
istics identical to those of the primary, thus spilling
further satellites. Thus, satellites of smaller turnouts
consist of single cells. This appears likely when one
assumes that the spread of satellites is a continuous
process, that may progress parallel to, and with the
same growth kinetics as, the original turnout.
Accordingly, a satellite tumour may develop out of
every remote cell. Tumour mass increases with time,
during which, satellites may also grow into a state of
relative radioresistance. Tumours of 1.1 g have
already had enough time to produce satellites that
obey similar radiobiological laws as primary tumours.
Previously, it was shown that R1H tumours exceed-
ing 1 mm3 cannot be cured by RT alone using
60 Gy.
16 Hypoxia is held responsible for the relatively
high radioresistance in the RIH tumour system.
18
Hence, hypoxia might also be important in the
satellites of primary tumours larger than 1.1 g.
As the satellites are not yet macroscopically detect-
able during surgery, they may remain in situ. There
is no obligatory connection to supplying blood ves-
sels. Accordingly, the actual tumour and its satellites
are in a competitive situation. By excising the main
tumour, all the nutritive supply of the tumour bed
becomes concentrated in the remaining smaller cell
formations. This may, in addition to operation-
induced growth factors,
9 serve as an explanation for
the observation of faster tumour regrowth following
surgery rather than after transplantation. The fact
that 80% of all recurring tumours occurred within 14
days supports this theory.
The results presented are considered to be of
clinical interest. Particularly in early and limited
tumours, post-operative RT can sterilize these
remaining cells and thus improve outcome. This has
been shown for gynaecological cancers,3’4’19-21 breast
cancers,6’7 and head and neck tumours, as well as
for sarcomas. 1’1
Similar to clinical tumours eccentric cell migration
plays an important role in experimental tumours.
Thus, the migration phenomenon has to be taken
into consideration when defining the target volume
for RT. Concentric, solid cell formations require
larger doses than eccentric single cells, and larger
tumours demand larger surgical safety margins. This
is despite the need for smaller photon doses at the
periphery. On the one hand, penumbra irradiation
has a positive impact on the outcome. On the other
hand, new and more precise irradiation techniques
such as 3-D planned multi-leafcollimator techniques
and proton irradiation reduce the size of the penum-
bra volume, thus increasing the risk ofleaving persist-
ing tumour cells untreated.
The experimental data provided show that even
small tumours may have an unexpected high recur-
rence rate following surgery alone, especially when
the extent of surgical treatment is limited for several
reasons. The outcome can be improved significantly
by consequent application of post-operative RT.
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